HomeCompareFXLV vs JNJ

FXLV vs JNJ: Dividend Comparison 2026

FXLV yields 11764.71% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FXLV wins by $274007141838937440.00M in total portfolio value
10 years
FXLV
FXLV
● Live price
11764.71%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$274007141838937440.00M
Annual income
$269,500,875,232,648,100,000,000.00
Full FXLV calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FXLV vs JNJ

📍 FXLV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFXLVJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FXLV + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FXLV pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FXLV
Annual income on $10K today (after 15% tax)
$1,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$229,075,743,947,750,880,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, FXLV beats the other by $229,075,743,947,750,880,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FXLV + JNJ for your $10,000?

FXLV: 50%JNJ: 50%
100% JNJ50/50100% FXLV
Portfolio after 10yr
$137003570919468720.00M
Annual income
$134,750,437,616,324,060,000,000.00/yr
Blended yield
98.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FXLV
Analyst Ratings
6
Hold
Consensus: Hold
Price Target
$9.25
+54311.8% upside vs current
Range: $3.00 — $15.00
Altman Z
-7.9
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FXLV buys
0
JNJ buys
0
No recent congressional trades found for FXLV or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFXLVJNJ
Forward yield11764.71%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$274007141838937440.00M$20.0K
Annual income after 10y$269,500,875,232,648,100,000,000.00$827.78
Total dividends collected$273708042374235968.00M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$9.25$228.73

Year-by-year: FXLV vs JNJ ($10,000, DRIP)

YearFXLV PortfolioFXLV Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,187,171$1,176,470.59$10,676$355.77+$1.18MFXLV
2$131,800,299$130,530,026.19$11,407$389.39+$131.79MFXLV
3$13,684,495,179$13,543,468,859.19$12,198$426.53+$13684.48MFXLV
4$1,328,833,511,111$1,314,191,101,269.97$13,056$467.62+$1328833.50MFXLV
5$120,687,819,296,315$119,265,967,439,426.02$13,987$513.12+$120687819.28MFXLV
6$10,252,517,989,034,712$10,123,382,022,387,654.00$14,998$563.56+$10252517989.02MFXLV
7$814,697,916,193,230,300$803,727,721,944,963,200.00$16,098$619.52+$814697916193.21MFXLV
8$60,560,305,243,650,090,000$59,688,578,473,323,330,000.00$17,295$681.69+$60560305243650.07MFXLV
9$4,211,464,118,027,432,000,000$4,146,664,591,416,727,000,000.00$18,599$750.82+$4211464118027432.00MFXLV
10$274,007,141,838,937,430,000,000$269,500,875,232,648,100,000,000.00$20,022$827.78+$274007141838937440.00MFXLV

FXLV vs JNJ: Complete Analysis 2026

FXLVStock

F45 Training Holdings Inc. operates as a fitness franchisor. The company offers consumers functional 45-minute workouts that combine elements of high-intensity interval, circuit, and functional training. It provides workouts primarily through its digitally-connected network of studios. As of December 31, 2021, the company operated 1,749 total studios. It has operations in the United States, South America, Australia, New Zealand and surrounding island nations, and internationally. The company was formerly known as Flyhalf Holdings Inc. and changed its name to F45 Training Holdings Inc. in March 2019. F45 Training Holdings Inc. was founded in 2013 and is headquartered in Austin, Texas.

Full FXLV Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FXLV vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FXLV vs SCHDFXLV vs JEPIFXLV vs OFXLV vs KOFXLV vs MAINFXLV vs ABBVFXLV vs MRKFXLV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.